Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin-Reference-Cited by-同舟云学术

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin

Published:2012-01 Issue:1 Volume:56 Page:34-40
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Huang Chung-Feng,Huang Jee-Fu,Yang Jeng-Fu,Hsieh Ming-Yen,Lin Zu-Yau,Chen Shinn-Cherng,Wang Liang-Yen,Juo Suh-Hang Hank,Chen Ku-Chung,Chuang Wan-Long,Kuo Hsing-Tao,Dai Chia-Yen,Yu Ming-Lung

Publisher

Elsevier BV

Subject

Hepatology

Reference44 articles.

1. IL28B and the control of hepatitis C virus infection;Balagopal;Gastroenterology,2010

2. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients;Berg;Hepatology,2009

3. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients;Dai;J Hepatol,2009

4. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response;Ferenci;Gastroenterology,2008

5. Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation;Fukuhara;J Hepatol,2010

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection;Journal of Hepatology;2020-07

2. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study;Journal of the Formosan Medical Association;2019-06

3. Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals;Hepatology International;2018-11

4. Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals;Scientific Reports;2018-10-10

5. A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders;Journal of the Chinese Medical Association;2018-08